These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26915028)

  • 1. Comparison of Refractive Error Changes in Retinopathy of Prematurity Patients Treated with Diode and Red Lasers.
    Roohipoor R; Karkhaneh R; Riazi Esfahani M; Alipour F; Haghighat M; Ebrahimiadib N; Zarei M; Mehrdad R
    Ophthalmologica; 2016; 235(3):173-8. PubMed ID: 26915028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes.
    Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D
    Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study.
    Alqurashi L; Alfaraidi A; Almahmoudi F; Danish E; Hadrawi M
    Middle East Afr J Ophthalmol; 2023; 30(1):37-43. PubMed ID: 38435111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period.
    Gunn DJ; Cartwright DW; Yuen SA; Gole GA
    Clin Exp Ophthalmol; 2013 Mar; 41(2):159-66. PubMed ID: 22712637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy.
    Kuo HK; Sun IT; Chung MY; Chen YH
    Ophthalmologica; 2015; 234(4):211-7. PubMed ID: 26393895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.
    Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB
    Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity.
    McLoone EM; O'Keefe M; McLoone SF; Lanigan BM
    J AAPOS; 2006 Oct; 10(5):454-9. PubMed ID: 17070482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
    Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
    Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of solid-state 532 nm green laser in high-risk retinopathy of prematurity at a tertiary care centre in India.
    Chhabra K; Kaur P; Singh K; Aggarwal A; Chalia D
    Int Ophthalmol; 2018 Feb; 38(1):287-291. PubMed ID: 28204988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transscleral diode laser retinal photocoagulation for the treatment of threshold retinopathy of prematurity.
    Parvaresh MM; Modarres M; Falavarjani KG; Sadeghi K; Hammami P
    J AAPOS; 2009 Dec; 13(6):535-8. PubMed ID: 20006811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.
    Yang CS; Wang AG; Shih YF; Hsu WM
    Acta Ophthalmol; 2013 Jun; 91(4):e276-82. PubMed ID: 23601812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficiency of 810 nm diode laser photocoagulation for type1 retinopathy of prematurity].
    Chen Y; Li F; Deng X; Yin H; Liang J; Zhao M; Li X
    Zhonghua Yan Ke Za Zhi; 2015 Nov; 51(11):814-7. PubMed ID: 26850581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diode laser photocoagulation posterior to the ridge in severe stage 3+ threshold retinopathy of prematurity.
    Arvas S; Sarici AM; Akar S
    Cutan Ocul Toxicol; 2014 Sep; 33(3):197-200. PubMed ID: 24147941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity.
    Paysse EA; Hussein MA; Miller AM; Brady McCreery KM; Coats DK
    J AAPOS; 2007 Aug; 11(4):388-92. PubMed ID: 17306999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior segment complications after diode laser photocoagulation for prethreshold retinopathy of prematurity.
    Salgado CM; Celik Y; VanderVeen DK
    Am J Ophthalmol; 2010 Jul; 150(1):6-9.e2. PubMed ID: 20227677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diode laser photocoagulation for retinopathy of prematurity--outcomes in one-year observation].
    Kobylarz J; Piwowarczyk A; Romanowska-Dixon B
    Klin Oczna; 2006; 108(1-3):36-8. PubMed ID: 16883937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.
    Gunay M; Celik G; Ovali F; Yetik H; Aktas A; Gunay BO
    Int Ophthalmol; 2015 Feb; 35(1):27-35. PubMed ID: 25381161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cataract development by 6 months' corrected age in the Early Treatment for Retinopathy of Prematurity study.
    Davitt BV; Christiansen SP; Hardy RJ; Tung B; Good WV;
    J AAPOS; 2013 Feb; 17(1):49-53. PubMed ID: 23352719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Refraction and visual acuity after laser coagulation treatment for retinopathy of prematurity in stage 3+].
    Récsán Z; Szamosi A; Karkó C; Vámos R; Sebestyén M; Fodor M; Salacz G
    Ophthalmologe; 2004 Jan; 101(1):45-9. PubMed ID: 14872267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.